Abstract:Insufficient outcomes amongst adults with major depressive disorder (MDD) provide the impetus to identify and refine therapeutic targets that are most critical to outcome from patient, provider, and societal perspectives. Towards this aim, a pivotal shift towards the transnosological domain, cognition, is occurring in the study of MDD and other brain disorders. This paper aims to provide a framework for conceptualizing and prioritizing cognitive function amongst adults with MDD with a particular view to provide a conceptual framework for research and clinical priorities. We also summarize extant data pertaining to psychotropic effects, notably antidepressants, on the cognitive dimension/domain. This narrative review was based on articles identified through a PubMed/MEDLINE search of all English-language articles published between January 1966 and October 2014. The search words were major depressive disorder, depression, unipolar depression, cognition, cognitive dysfunction, cognitive deficit, and cognitive function. The search was supplemented with a manual review of relevant references. The selection of articles for inclusion in this review was based on overall methodological quality as well as on their pertinence to informing the framework described herein. Cognitive dysfunction in MDD is a discrete domain subserved by discrete yet overlapping substrates. There is a need to provide a glossary of terms commonly employed in the cognition literature for consensus as to the appropriate screening, measurement, and monitoring tools. The guiding principle of measurement-based care should include systematic assessment and measurement of cognition in subpopulations with MDD, as a tactic to improve outcome. Relatively few treatment strategies have demonstrated efficacy specifically for the cognitive domain in MDD. The antidepressant vortioxetine has replicated evidence of specific pro-cognitive effects in adults with MDD across multiple subdomains of cognitive function. Vortioxetine is a novel antidepressant that is hypothesized to act through a combination of direct effects on receptor activity and serotonin receptor inhibition, as well as other systems. Pro-cognitive effects for other US FDA-approved agents are suggested, but pseudospecificity has not been excluded as a possible explanation of their beneficial effects on cognitive function. A disparate assortment of other agents are currently under investigation for possible benefit in mitigating cognitive deficits and improving cognitive performance (e.g., intranasal insulin, erythropoietin, anti-inflammatory agents). Non-pharmacological approaches including, but not limited to, cognitive remediation (CR), aerobic exercise, and neuromodulation are promising.

Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression

A theory of the neural mechanisms underlying negative cognitive bias in major depression

Depression: A cognitive perspective

Neurobiological Investigation of Depression: Unraveling the Biological Basis of a Complex Mental Health Challenge

Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research

A Hot-Cold Cognitive Model of Depression: Integrating the Neuropsychological Approach Into the Cognitive Theory Framework

Neurophysiology of Motivated Learning: Adaptive Mechanisms Underlying Cognitive Bias in Depression

Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression – A systematic review

Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants

The antidepressant effect of cognitive reappraisal training on individuals cognitively vulnerable to depression: Could cognitive bias be modified through the prefrontal–amygdala circuits?

5-HT2A mediated plasticity as a target in major depression: a narrative review connecting the dots from neurobiology to cognition and psychology

Neuropsychological Mechanism Underlying Antidepressant Effect: a Systematic Meta-Analysis.

The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder

Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression

Cognitive and Neural Aspects of Information Processing in Major Depressive Disorder: An Integrative Perspective

The Revised Monoamine Theory of Depression: A Modulatory Role for Monoamines, Based on New Findings From Monoamine Depletion Experiments in Humans

Computational approaches to treatment response prediction in major depression using brain activity and behavioral data: A systematic review

Cognitive Control in Depression: Toward Clinical Models Informed by Cognitive Neuroscience

Neurocognitive therapeutics: from concept to application in the treatment of negative attention bias

Cognitive Impairment Along the Course of Depression: Non-Pharmacological Treatment Options